Office of Research & Development |
![]() ![]() |
Project Number: | I01CX000916-05 |
Title: | Signaling Pathways and Therapeutic Targeting of Leukemic Cells |
Principal Investigator: | Leonidas C. Platanias |
Location: | Chicago, IL |
Congressional District Code: | 7 |
Research Service: | Clinical Science R&D |
Project Period: | July 2018 - June 2022 |
FY 2021 Funding Amount: | $165,000 |
Total Award Amount (all years): |
$703,250 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: This is a competing renewal application focused on the mechanisms of leukemogenesis and the identification of new targets for the treatment of acute myeloid leukemia (AML). Developing novel therapeutic approaches for the treatment of AML is of high clinical translational relevance and importance, as the outcome for the majority of patients with acute myeloid leukemia (AML) remains very poor, despite recent advances in the field. The emergence of leukemic cell resistance continues to be a serious... |